Jessica Garcia
Pediatric Hematology-Oncology · Dallas, TXNPI 1295099752
Payments from drug & device makers
What this record shows
The money is spread across several categories — consulting fees (59.5%), speaking fees and travel and lodging — rather than concentrated in one kind of arrangement. 9 manufacturers reported payments, led by Sanofi at 41.8% of the total. 2025 is the largest year on record at $33,878, more than ten times the $127 reported in 2019. Among pediatric hematology-oncology clinicians in TX with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 87 payments — averaging $781.54 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Sanofi$28K
- Genentech USA, Inc.$21K
- Octapharma USA, Inc.$13K
- HEMA Biologics, LLC$3K
- Bayer$2K
- Pfizer$2K
- plus $84 from 3 others
Across 65 payments — averaging $4216.15 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Sanofi$140K
- Octapharma USA, Inc.$68K
- Sanofi US Services Inc.$39K
- Diagnostica Stago, Inc$25K
- Regeneron$1K
What the payments were for
- Consulting fees$40,43259%
- Speaking & faculty fees$14,75622%
- Travel & lodging$9,08713%
- Food & beverage$3,7195%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Sanofi | 27 | $28,412 |
| Genentech USA, Inc. | 24 | $20,562 |
| Octapharma USA, Inc. | 26 | $12,702 |
| HEMA Biologics, LLC | 1 | $2,500 |
| Bayer | 3 | $2,215 |
| Pfizer | 2 | $1,519 |
| Heartflow, Inc. | 1 | $36 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 2 | $33 |
| KARL Storz Endoscopy-america | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- HEMLIBRA$19,882
- QFITLIA$16,355
- WILATE - VON WILLEBRAND FACTOR/COAGULATION FACTOR VIII COMPLEX (HUMAN)$7,847
- FIBRYGA & BALFAXAR$3,689
- SevenFact$2,500
- Jivi$2,176
- NUWIQ$661
- ALTUVIIIO$149
- BALFAXAR$107
How this compares
$67,994 in reported general payments places this provider in the 95th percentile of 235 pediatric hematology-oncology providers in Texas.
Other pediatric hematology-oncology in Dallas
- Stanton GoldmanDallas$234K
- Maurizio GhisoliDallas$174K
- Joel WeinthalDallas$161K
- Ayesha ZiaDallas$74K
- Matthew FletcherDallas$40K
- Janna JourneycakeDallas$19K
- Zora RogersDallas$15K
- Kathryn DickersonDallas$10K
- Laura KlesseDallas$9K
- Tanya WattDallas$5K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.